about
Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophagesProtein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its ComplicationsAnalyses of multiple single-nucleotide polymorphisms in the SUMO4/IDDM5 region in affected sib-pair families with type I diabetes.SUMO-4: A novel functional candidate in the human placental protein SUMOylation machinery.Commonalities of genetic resistance to spontaneous autoimmune and free radical--mediated diabetes.Negative regulation of C/EBPbeta1 by sumoylation in breast cancer cells.In vitro phenotypic, genomic and proteomic characterization of a cytokine-resistant murine β-TC3 cell lineEhrlichia chaffeensis exploits host SUMOylation pathways to mediate effector-host interactions and promote intracellular survival.SUMO--a post-translational modification with therapeutic potential?Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD miceInternal calibration Förster resonance energy transfer assay: a real-time approach for determining protease kinetics.HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes.Engineering pre-SUMO4 as efficient substrate of SENP2.Novel roles of SUMO in pancreatic β-cells: thinking outside the nucleus.Sumoylation at the host-pathogen interface.SUMO rules: regulatory concepts and their implication in neurologic functions.Sumoylation Modulates the Susceptibility to Type 1 Diabetes.The Roles of SUMO in Metabolic Regulation.SETX sumoylation: A link between DNA damage and RNA surveillance disrupted in AOA2.Small ubiquitin-like modifier-4 Met55Val polymorphism is associated with glycemic control of Type 2 diabetes mellitus in Taiwan.Interplay of the fungal sumoylation network for control of multicellular development.Spatiotemporal distribution of small ubiquitin-like modifiers during human placental development and in response to oxidative and inflammatory stress.A proteomic study of the regulatory role for STAT-1 in cytokine-induced beta-cell death.
P2860
Q21296830-3FA1F987-668E-4971-871B-995743E18B1AQ26752842-5F963DA3-674F-43B2-8D63-8800CABF0147Q33587978-ACC7829A-F93E-4137-98DD-42E01F7AAAD4Q33699071-047C2DBD-F9C6-40CE-94B0-B555EEFBEF78Q33857810-3D1A68DF-615B-431E-9FFA-F4A6DDE10D81Q34042983-25D8C7EC-E391-4E9E-A41E-3B401832B701Q34185773-33C09B9C-8893-42B0-B301-618A1A153211Q34298587-9E127F91-5EA8-49DB-8952-6E97B36B7790Q34400369-BCF834A9-1CB7-47B0-B5E0-DCA6C6C5016FQ36807621-1CBA0069-3B3D-4EAF-861C-B9EB08201D84Q36904152-2C6F6D34-2530-4FD1-A4CD-CB95C2E7F710Q37418804-DE7F76B2-2C72-413F-B649-3E001DCF6D6BQ37665382-5EABC3A9-7A8A-435D-BA89-1B4DAF778538Q38001061-EB6C33F0-DC50-4337-AE62-E7BCC6971FA2Q38116514-4A378097-B9BE-43F2-A332-020223C4A296Q38132691-69BE194E-574F-44A3-832F-7D96E2042E0BQ38961119-223B3719-5BA0-4058-855C-8B9C8D65B164Q39136006-E82E8565-A9C9-4059-80D4-D5869FCE8B5DQ42143254-A3CC3DED-5ED0-4403-B6F0-D9B14534AD7FQ43241836-BD040F79-2DA5-48CB-BA13-8EFA24BB8C8FQ46741600-3AE01855-0B5C-45A2-A05B-F645177888BFQ52691006-715365C5-C166-45C2-A100-B0D971E905F4Q53604777-C1DF28D4-9444-409D-9BEE-C95273AEF8F9
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
SUMO4 and its role in type 1 diabetes pathogenesis.
@ast
SUMO4 and its role in type 1 diabetes pathogenesis.
@en
SUMO4 and its role in type 1 diabetes pathogenesis.
@nl
type
label
SUMO4 and its role in type 1 diabetes pathogenesis.
@ast
SUMO4 and its role in type 1 diabetes pathogenesis.
@en
SUMO4 and its role in type 1 diabetes pathogenesis.
@nl
prefLabel
SUMO4 and its role in type 1 diabetes pathogenesis.
@ast
SUMO4 and its role in type 1 diabetes pathogenesis.
@en
SUMO4 and its role in type 1 diabetes pathogenesis.
@nl
P2860
P356
P1476
SUMO4 and its role in type 1 diabetes pathogenesis.
@en
P2093
Cong-Yi Wang
Jin-Xiong She
P2860
P304
P356
10.1002/DMRR.797
P577
2008-02-01T00:00:00Z